Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimens

Medicaid Prior Authorization Policies for Pediatric Use of Antipsychotic Medications

(2015) Ian Schmid et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Atypical antipsychotic initiation and the risk of type II diabetes in children and adolescents

(2015) Minji Sohn et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Metabolic Monitoring for Youths Initiating Use of Second-Generation Antipsychotics, 2003–2011

(2015) John G. Connolly et al.   PSYCHIATRIC SERVICES

Quality Concerns in Antipsychotic Prescribing for Youth: A Review of Treatment Guidelines

(2014) Edith Kealey et al.   Academic Pediatrics

The Effects of Prior Authorization Policies on Medicaid-Enrolled Children's Use of Antipsychotic Medications: Evidence from Two Mid-Atlantic States

(2014) Bradley D. Stein et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Child and Adolescent Psychiatrists' Attitudes and Practices Prescribing Second Generation Antipsychotics

(2014) Angie Mae Rodday et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Atypical Antipsychotic Use Among Medicaid-Insured Children and Adolescents: Duration, Safety, and Monitoring Implications

(2014) Mehmet Burcu et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Risk of Diabetes in Children and Adolescents Exposed to Antipsychotics: A Nationwide 12-Year Case-Control Study

(2014) René Ernst Nielsen et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Pediatric Psychopharmacology: Food and Drug Administration Approval Through the Evidence Lens

(2014) Boris Lorberg et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Growth in the Concurrent Use of Antipsychotics With Other Psychotropic Medications in Medicaid-Enrolled Children

(2014) Amanda R. Kreider et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Adherence to Guidelines for Glucose Assessment in Starting Second-Generation Antipsychotics

(2014) M. A. Raebel et al.   PEDIATRICS

Collaborative Care Outcomes for Pediatric Behavioral Health Problems: A Cluster Randomized Trial

(2014) D. J. Kolko et al.   PEDIATRICS

Validation of a claims-based antipsychotic polypharmacy measure

(2014) Emily Leckman-Westin et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Trends in Psychotropic Polypharmacy Among Youths Enrolled in Ohio Medicaid, 2002–2008

(2014) Cynthia A. Fontanella et al.   PSYCHIATRIC SERVICES

Foster Care, Externalizing Disorders, and Antipsychotic Use Among Medicaid-Enrolled Youths

(2014) Lauren Vanderwerker et al.   PSYCHIATRIC SERVICES

Geographic Variation in Receipt of Psychotherapy in Children Receiving Attention-Deficit/Hyperactivity Disorder Medications

(2014) Walid F. Gellad et al.   JAMA Pediatrics

Metabolic Monitoring in Commercially Insured Pediatric Patients Newly Initiated to Take a Second-Generation Antipsychotic

(2014) Thomas Delate et al.   JAMA Pediatrics

Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment

(2013) Nitin Toteja et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

APA Targets Unnecessary Antipsychotic Use

(2013) Bridget M. Kuehn   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Trends in the Parent-Report of Health Care Provider-Diagnosed and Medicated Attention-Deficit/Hyperactivity Disorder: United States, 2003–2011

(2013) Susanna N. Visser et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Stimulant and Atypical Antipsychotic Medications For Children Placed in Foster Homes

(2013) L. Oriana Linares et al.   PLoS One

Pharmacoepidemiology of Antipsychotic Use in Youth with ADHD: Trends and Clinical Implications

(2013) Michael L. Birnbaum et al.   Current Psychiatry Reports

Recent Trends in Childhood Attention-Deficit/Hyperactivity Disorder

(2013) Darios Getahun et al.   JAMA Pediatrics

Antipsychotics and the Risk of Type 2 Diabetes Mellitus in Children and Youth

(2013) William V. Bobo et al.   JAMA Psychiatry

National Trends in the Mental Health Care of Children, Adolescents, and Adults by Office-Based Physicians

(2013) Mark Olfson et al.   JAMA Psychiatry

National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics

(2012) Mark Olfson et al.   ARCHIVES OF GENERAL PSYCHIATRY

Metabolic Screening in Children Receiving Antipsychotic Drug Treatment

(2012) Elaine H. Morrato et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

The Relationship between Mental Health Diagnosis and Treatment with Second-Generation Antipsychotics over Time: A National Study of U.S. Medicaid-Enrolled Children

(2012) Meredith Matone et al.   HEALTH SERVICES RESEARCH

Treatment of Maladaptive Aggression in Youth: CERT Guidelines II. Treatments and Ongoing Management

(2012) N. Scotto Rosato et al.   PEDIATRICS

Antipsychotic Use by Medicaid-Insured Youths: Impact of Eligibility and Psychiatric Diagnosis Across a Decade

(2012) Julie Magno Zito et al.   PSYCHIATRIC SERVICES

Conflicting Data on Psychotropic Use by Children

(2012) David Rubin   JAMA Pediatrics

Antipsychotic Medication Use Among Children and Risk of Diabetes Mellitus

(2011) S. E. Andrade et al.   PEDIATRICS

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

(2011) G. C. Alexander et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Using freelisting to understand shared decision making in ADHD: Parents’ and pediatricians’ perspectives

(2010) Alexander G. Fiks et al.   PATIENT EDUCATION AND COUNSELING

Contrasting Parents' and Pediatricians' Perspectives on Shared Decision-Making in ADHD

(2010) A. G. Fiks et al.   PEDIATRICS

Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users

(2010) Elaine H. Morrato et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Broadened Use Of Atypical Antipsychotics: Safety, Effectiveness, And Policy Challenges

(2009) Stephen Crystal et al.   HEALTH AFFAIRS

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Implications of Marked Weight Gain Associated With Atypical Antipsychotic Medications in Children and Adolescents

(2009) Christopher K. Varley   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Weight Gain and Metabolic Abnormalities During Extended Risperidone Treatment in Children and Adolescents

(2009) Chadi A. Calarge et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Metabolic and Cardiovascular Adverse Events Associated With Antipsychotic Treatment in Children and Adolescents

(2008) Roger S. McIntyre et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Adverse events in children and adolescents treated with antipsychotic medications

(2008) Jeanette M. Jerrell et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL